The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.

We did not find that the TERT promoter mutation status is an independent prognostic biomarker of primary GBM, even though the TERT mutation status analyses revealed borderline significance in the univariate survival analysis (Figure 3 E).

also in 7,017 other papers